Yuhai Lu
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Metabolic rate-limiting enzyme-associated genes as novel biomarkers for prognosis and treatment response in lung adenocarcinoma.
Journal: Computer methods in biomechanics and biomedical engineering
Published: July 02, 2026
Small-cell transformation of advanced non-small-cell lung cancer harboring driver mutations following tyrosine kinase inhibitor therapy: a multicenter real-world study.
Journal: Journal of thoracic disease
Published: February 26, 2026
Erratum: CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas: Erratum.
Journal: Journal of Cancer
Published: April 30, 2025
The effects of surgical resection in the treatment of limited-stage small cell lung cancer: a multicenter retrospective study.
Journal: Updates in surgery
Published: September 05, 2023
Serum THBS2 is a potential biomarker for the diagnosis of non-small cell lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: July 24, 2023
CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas.
Journal: Journal of Cancer
Published: July 11, 2023
The Effect of miR-505-5p on Inhibition of Serum Uromodulin Ameliorates Myocardial Inflammation and Apoptosis Induced by Ischemia-Reperfusion.
Journal: Oxidative medicine and cellular longevity
Published: August 09, 2022
LncRNA BBOX1-AS1 targets miR-361-3p/COL1A1 axis to drive the progression of oesophageal carcinoma.
Journal: European journal of clinical investigation
Published: May 11, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026